Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is OSELTAMIVIR PHOSPHATE USP, with a corresponding US DMF Number 30012.
Remarkably, this DMF maintains an Active status since its submission on November 30, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 27, 2016, and payment made on June 17, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II